Jacobs K, Shoemaker C, Rudersdorf R, Neill S D, Kaufman R J, Mufson A, Seehra J, Jones S S, Hewick R, Fritsch E F
Nature. 1985;313(6005):806-10. doi: 10.1038/313806a0.
The glycoprotein hormone erythropoietin regulates the level of oxygen in the blood by modulating the number of circulating erythrocytes, and is produced in the kidney or liver of adult and the liver of fetal or neonatal mammals. Neither the precise cell types that produce erythropoietin nor the mechanisms by which the same or different cells measure the circulating oxygen concentration and consequently regulate erythropoietin production are known. Cells responsive to erythropoietin have been identified in the adult bone marrow, fetal liver or adult spleen. In cultures of erythropoietic progenitors, erythropoietin stimulates proliferation and differentiation to more mature red blood cells. Detailed molecular studies have been hampered, however, by the impurity and heterogeneity of target cell populations and the difficulty of obtaining significant quantities of the purified hormone. Highly purified erythropoietin may be useful in the treatment of various forms of anaemia, particularly in chronic renal failure. Here we describe the cloning of the human erythropoietin gene and the expression of an erythropoietin cDNA clone in a transient mammalian expression system to yield a secreted product with biological activity.
糖蛋白激素促红细胞生成素通过调节循环红细胞的数量来调控血液中的氧含量,在成年哺乳动物的肾脏或肝脏以及胎儿或新生儿哺乳动物的肝脏中产生。目前既不清楚产生促红细胞生成素的确切细胞类型,也不了解相同或不同细胞测量循环氧浓度并因此调节促红细胞生成素产生的机制。在成年骨髓、胎儿肝脏或成年脾脏中已鉴定出对促红细胞生成素作出反应的细胞。在促红细胞生成祖细胞培养物中,促红细胞生成素刺激增殖并分化为更成熟的红细胞。然而,详细的分子研究受到靶细胞群体的杂质和异质性以及难以获得大量纯化激素的阻碍。高度纯化的促红细胞生成素可能对治疗各种形式的贫血有用,尤其是在慢性肾衰竭中。在此,我们描述了人类促红细胞生成素基因的克隆以及促红细胞生成素cDNA克隆在瞬时哺乳动物表达系统中的表达,以产生具有生物活性的分泌产物。